Background: Epidemiological studies have linked adult height with breast cancer risk in women. However, the magnitude of the association, particularly by subtypes of breast cancer, has not been established. Furthermore, the mechanisms of the association remain unclear.
Methods: We performed a meta-analysis to investigate associations between height and breast cancer risk using data from 159 prospective cohorts totaling 5216302 women, including 113178 events. In a consortium with individual-level data from 46325 case patients and 42482 control patients, we conducted a Mendelian randomization analysis using a genetic score that comprised 168 height-associated variants as an instrument. This association was further evaluated in a second consortium using summary statistics data from 16003 case patients and 41335 control patients.
Results: The pooled relative risk of breast cancer was 1.17 (95% confidence interval [CI] = 1.15 to 1.19) per 10cm increase in height in the meta-analysis of prospective studies. In Mendelian randomization analysis, the odds ratio of breast cancer per 10cm increase in genetically predicted height was 1.22 (95% CI = 1.13 to 1.32) in the first consortium and 1.21 (95% CI = 1.05 to 1.39) in the second consortium. The association was found in both premenopausal and postmenopausal women but restricted to hormone receptor-positive breast cancer. Analyses of height-associated variants identified eight new loci associated with breast cancer risk after adjusting for multiple comparisons, including three loci at 1q21.2, DNAJC27, and CCDC91 at genome-wide significance level P < 5×10(-8).
Conclusions: Our study provides strong evidence that adult height is a risk factor for breast cancer in women and certain genetic factors and biological pathways affecting adult height have an important role in the etiology of breast cancer.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: firstname.lastname@example.org.
Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.PLoS Med. 2016 Sep 6;13(9):e1002118. doi: 10.1371/journal.pmed.1002118. eCollection 2016 Sep. PLoS Med. 2016. PMID: 27598322 Free PMC article.
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.PLoS Med. 2016 Aug 23;13(8):e1002105. doi: 10.1371/journal.pmed.1002105. eCollection 2016 Aug. PLoS Med. 2016. PMID: 27551723 Free PMC article.
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.Int J Epidemiol. 2019 Jun 1;48(3):795-806. doi: 10.1093/ije/dyy201. Int J Epidemiol. 2019. PMID: 30277539
Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer.Int J Epidemiol. 2016 Jun;45(3):896-908. doi: 10.1093/ije/dyw129. Epub 2016 Jul 17. Int J Epidemiol. 2016. PMID: 27427428 Free PMC article.
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.Epidemiol Rev. 2014;36(1):114-36. doi: 10.1093/epirev/mxt010. Epidemiol Rev. 2014. PMID: 24375928 Free PMC article. Review.
Cited by 38 articles
Assessment Causality in Associations Between Serum Uric Acid and Risk of Schizophrenia: A Two-Sample Bidirectional Mendelian Randomization Study.Clin Epidemiol. 2020 Feb 26;12:223-233. doi: 10.2147/CLEP.S236885. eCollection 2020. Clin Epidemiol. 2020. PMID: 32161502 Free PMC article.
Obstructive sleep apnea syndrome and causal relationship with female breast cancer: a mendelian randomization study.Aging (Albany NY). 2020 Feb 29;12(5):4082-4092. doi: 10.18632/aging.102725. Epub 2020 Feb 29. Aging (Albany NY). 2020. PMID: 32112550 Free PMC article.
Genetically Determined Height and Risk of Non-hodgkin Lymphoma.Front Oncol. 2020 Jan 28;9:1539. doi: 10.3389/fonc.2019.01539. eCollection 2019. Front Oncol. 2020. PMID: 32064237 Free PMC article.
Anthropometry, body shape in early-life and risk of premenopausal breast cancer among Latin American women: results from the PRECAMA study.Sci Rep. 2020 Feb 10;10(1):2294. doi: 10.1038/s41598-020-59056-6. Sci Rep. 2020. PMID: 32042008 Free PMC article.
Early-Life and Adult Anthropometrics in Relation to Mammographic Image Intensity Variation in the Nurses' Health Studies.Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):343-351. doi: 10.1158/1055-9965.EPI-19-0832. Epub 2019 Dec 11. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31826913
- CA54281/CA/NCI NIH HHS/United States
- CA128978/CA/NCI NIH HHS/United States
- R35 CA197449/CA/NCI NIH HHS/United States
- R01 CA176785/CA/NCI NIH HHS/United States
- P30 CA016056/CA/NCI NIH HHS/United States
- C5047/A10692/Cancer Research UK/United Kingdom
- P30 CA015704/CA/NCI NIH HHS/United States
- RG/08/014/24067/British Heart Foundation/United Kingdom
- C490/A10124/Cancer Research UK/United Kingdom
- 1U19 CA148065/CA/NCI NIH HHS/United States
- U01 CA164930/CA/NCI NIH HHS/United States
- 1U19 CA148537/CA/NCI NIH HHS/United States
- MR/L003120/1/Medical Research Council/United Kingdom
- CA63464/CA/NCI NIH HHS/United States
- U01 CA116167/CA/NCI NIH HHS/United States
- C5047/A8384/Cancer Research UK/United Kingdom
- C12292/A11174/Cancer Research UK/United Kingdom
- R01 CA128978/CA/NCI NIH HHS/United States
- CA116167/CA/NCI NIH HHS/United States
- Canadian Institutes of Health Research/Canada
- CA176785/CA/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- C1287/A 10710/Cancer Research UK/United Kingdom
- 1U19 CA148112/CA/NCI NIH HHS/United States
- C1281/A12014/Cancer Research UK/United Kingdom
- R37CA070867/CA/NCI NIH HHS/United States
- CA132839/CA/NCI NIH HHS/United States
- C1287/A10118/Cancer Research UK/United Kingdom
- UM1 CA164920/CA/NCI NIH HHS/United States
- CA098758/CA/NCI NIH HHS/United States
- UM1 CA182910/CA/NCI NIH HHS/United States
- U01 CA164973/CA/NCI NIH HHS/United States
- C5047/A15007/Cancer Research UK/United Kingdom
- 10124/Cancer Research UK/United Kingdom